focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: Lower Call; Shire Agrees Takeda Deal

Tue, 08th May 2018 07:47

LONDON (Alliance News) - Stock prices in London are seen opening lower on Tuesday ahead of US President Donald Trump's decision on whether to scrap the nuclear deal with Iran, while in London Shire announced a takeover agreement with Japan's Takeda Pharmaceutical and CYBG has approached fellow UK challenger bank Virgin Money for an all-share merger.

Trump is set to make the announcement at the White House at 1900 BST.

France, Germany, and Britain have launched a diplomatic offensive in recent weeks to try to persuade Trump not to scuttle the deal. But French President Emmanuel Macron has already said their efforts may have failed.

Trump said he opposed the agreement during the 2016 presidential campaign and in office has repeatedly threatened to pull the US out of the pact, last week calling it a "horrible deal".

UK Foreign Secretary Boris Johnson said Monday that there was currently no viable alternative to the Iran deal.

The French and German foreign ministers pleaded with the US to uphold the agreement after a meeting in Berlin on Monday. There were "no alternatives" to the nuclear restrictions that Tehran had accepted, German Foreign Minister Heiko Maas said.

IG futures indicate the FTSE 100 index is to open 59.50 points lower at 7,566.10. The blue chip index closed up 0.9%, or 64.45 points, at 7,567.14 on Friday prior to a three-day holiday weekend in the UK, ending the week 0.9% higher.

In UK company news, Irish pharmaceutical firm Shire announced it has reached agreement for a takeover by Japanese peer Takeda.

Takeda is to pay USD30.33 in cash per share plus either 0.839 Takeda shares or 1.678 Takeda American depository shares.

Based on Takeda's closing price on April 23, the day before Shire said it would be willing to recommend a takeover, this values Shire at around GBP46.00 billion, though approximately GBP44.00 billion of this is based on Takeda's closing price on Monday in Tokyo.

Shire shareholders will own approximately 50% of the combined group

Meanwhile, CYBG confirmed on Tuesday it has made a "preliminary" approach regarding a GBP1.60 billion merger with Virgin Money Holding.

The bank would acquire all of Virgin Money at a ratio of 1.1297 CYBG shares per Virgin Money share, leaving the latter's shareholders with 36.5% of the enlarged company.

In the FTSE 100, Standard Life Aberdeen said it does not believe Lloyds Banking Group or Scottish Widows has the right the terminate the asset management arrangements between the parties.

Standard Life Aberdeen "does not agree" that following its creation through the merger of Aberdeen Asset Management and Standard Life that it is in competition with Lloyds in the UK, following the latter's mid-February cancellation of the asset management arrangements.

Chilean miner Antofagasta held full-year production guidance despite a blockage at its processing plant at the Los Pelambres mine.

The company said it will take three months for plant stockpiles to return to normal levels, with production in the first half at Los Pelambres to be around 10,000 tonnes of copper lower than expected and sales some 15,000 tonnes lower.

Back in the mid caps, bookmaker William Hill reported a 3% rise in group net revenue for the 17 weeks to April 24. Online revenue increased by 12% though retail fell 4%, with US operations posting revenue growth of 45% year-on-year.

Within online, sportsbook revenue fell 8% and in retail the figure dropped 13%.

William Hill said in online it had "very" strong football and horse racing results early in 20187, though an "average" Cheltenham festival and a flat Grand National year-on-year. A 1.3 percentage point increase in its gross win margin to 8.8% led to wagers falling 8% in the period.

Insurer Hiscox reported a 20% rise in first-quarter gross written premiums to USD1.16 billion at constant currency.

Hiscox's Retail gross written premiums increased 14% at constant currency year-on-year to USD572.9 million, London Market by 8.7% to USD219.8 million, and Re & ILS by 42% to USD363.1 million.

Chief Executive Bronek Masojada said: "After a costly year for catastrophes in 2017, our London Market and reinsurance businesses mobilised quickly to grasp the opportunity and grew strongly.

"Sadly, discipline and good sense is receding in the market, so for the rest of the year growth in big-ticket business will be more measured."

In the US on Monday, Wall Street ended up, with the Dow Jones Industrial Average 0.4% higher, S&P 500 up 0.4%, and Nasdaq Composite ending 0.8% up.

Crude oil prices reached a four-year high on Monday on the rising tensions between Iran and the US as Trump considers re-imposing sanctions on the country over its nuclear ambitions.

Oil was quoted at USD75.67 per barrel early on Tuesday.

In European economic news early Tuesday, Germany's industrial production recovered in March, provisional data from Destatis showed.

Industrial production grew by more-than-expected 1% month-on-month in March, reversing a 1.7% fall in February. Output was forecast to grow 0.8%.

Excluding energy and construction, industrial output advanced 1.1%. Energy output climbed 1.4% and construction advanced 0.6% in March.

On a yearly basis, industrial output logged a growth of 3.2% versus 2.2% increase in February. Economists had forecast an annual increase of 3%.

The Japanese Nikkei 225 index is closed 0.2% higher early Tuesday. In China, the Shanghai Composite is up 0.9%, while the Hang Seng index in Hong Kong is up 1.5%.

China's exports recovered at a faster than expected pace in April and imports growth accelerated notably, data from General Administration of Customs revealed Tuesday.

Exports advanced 13% year-on-year in April, reversing a 2.7% drop in March. Economists had forecast an increase of 8%.

At the same time, imports growth accelerated to 22% from 14% in the previous month. Imports were expected to rise 16%.

Consequently, the trade surplus totalled USD28.8 billion in April, above the expected level of USD27.75 billion.

In yuan terms, shipments gained 3.7% and imports logged a faster growth of 12% in April.

Still to come in the economic calendar on Tuesday, in the afternoon in the US the Redbook index is due at 1355 BST, with JOLTS job openings at 1500 BST.

More News
14 Sep 2018 09:15

Shire gains as takeover approved by China

(Sharecast News) - Japan's Takeda Pharmaceutical has received regulatory approval from China for its $62bn takeover of London-listed Shire.

Read more
13 Sep 2018 10:56

Takada eyeing potential Shire asset sales to pay down debt

(Sharecast News) - Takeda Pharmaceutical may try and sell Shire's dry-eye drug once it completes the $62bn takeover purchase of the UK-listed biotech, according to a report on Thursday.

Read more
13 Sep 2018 08:25

Takeda weighs sale of Shire's eye care business to cut debt- Bloomberg

Sept 13 (Reuters) - Japan's Takeda Pharmaceutical is considering selling Shire Plc's eye care business once it closes its $62 billion purchase of the London-listed drugmaker, as it looks a

Read more
12 Sep 2018 16:12

Takeda to pack up Illinois HQ, nearly 1,000 workers to be affected

Sept 12 (Reuters) - Japan's Takeda Pharmaceutical Co Ltd said on Wednesday it plans to shut its U.S. headquarters in Deerfield, Illinois and move it to the greater Boston area, following the —

Read more
12 Sep 2018 07:22

Shire gets EC marketing authorisation for 'VEYVONDI' treatment

(Sharecast News) - Rare diseases specialist Shire announced on Wednesday that the European Commission has granted marketing authorisation for 'VEYVONDI', for the treatment of bleeding events and the treatment and prevention of surgical bleeding in adults with von Willebrand disease, when desmopressin treatment alone is ineffective or not indicated.

Read more
10 Sep 2018 16:08

Two Shire Subsidiaries Receive Majority Early Offers For Senior Notes

LONDON (Alliance News) - Biotechnology company Shire PLC on Monday said two of its subsidiaries, Baxalta Inc and Shire Acquisitions Investments Ireland DAC, had received early offers for a of the

Read more
7 Sep 2018 09:33

BROKER RATINGS SUMMARY: Goldman Cuts Burberry; Redburn Cuts HSBC

LONDON (Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:----------FTSE 100----------GOLDMAN CUTS GROUP TO BUY -

Read more
6 Sep 2018 11:20

European Shares Reverse Early Losses On Improving Sentiment

BRUSSELS/FRANKFURT/PARIS (Alliance News) - European stocks were marginally higher on Thursday after having fallen to a five-month low earlier in the day.Sentiment improved somewhat after US

Read more
6 Sep 2018 10:54

TOP NEWS: Shire Buys Swiss Plasma Collection Firm Sanaplasma

LONDON (Alliance News) - Shire PLC said Thursday it has bought Swiss source plasma collection company sanaplasma AG for an undisclosed sum.The FTSE 100 pharmaceutical giant said that the is

Read more
6 Sep 2018 10:52

Shire buys Swiss plasma firm sanaplasma for undisclosed sum

(Sharecast News) - Pharmaceuticals giant Shire on Thursday said it had bought Switzerland's sanaplasma AG for an undisclosed sum.

Read more
6 Sep 2018 07:48

UPDATE 1-UK Stocks-Factors to watch on Sept. 6

Sept 6 (Reuters) - Britain's FTSE 100 futures were down 0.1 percent ahead of the cash market open on Thursday. * DIXONS CARPHONE: Dixons Carphone, the troubled British electricals and a

Read more
31 Aug 2018 10:16

Shire Completes USD2.4 Billion Oncology Franchise Sale To Servier

LONDON (Alliance News) - Irish biotechnology giant Shire PLC said Friday it has completed the sale of its oncology franchise to Servier SAS.The FTSE 100-listed company sold its franchise, a

Read more
31 Aug 2018 09:07

Shire completes $2.4bn oncology sale to Servier

(Sharecast News) - Shire has completed the sale of its oncology franchise to Servier for $2.4bn, it announced on Friday.

Read more
24 Aug 2018 14:04

TOP NEWS: Shire Launches Tender Offer To Buy Up To USD2 Billion Notes (ALLISS)

LONDON (Alliance News) - Biotechnology company Shire PLC on Friday said its wholly-owned subsidiaries Baxalta and Shire Acquisitions Investments Ireland DAC launched a tender offer to repurchase a

Read more
24 Aug 2018 13:54

MARKET ANALYSIS: Futures Pointing To Initial Strength On Wall Street

WASHINGTON (Alliance News) - The major US index futures are pointing to a higher opening on Friday, with stocks likely to move to the upside after ending the previous session modestly upward on a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.